Author: GT Medical Technologies

Novel Radiation Strategy Redefines a New Treatment Paradigm for Glioblastoma

August 18, 2026
ROADS Phase 3 Clinical Trial Data Presented at ASCO26 Show GammaTile® Provides Superior Tumor Control Leading to Patients Living Longer Without Recurrence Compared to Standard of Care in Newly Diagnosed Operable Brain Metastases

May 30, 2026

Novel Radiation Strategy Redefines a New Treatment Paradigm for Glioblastoma